SOXC transcription factors in mantle cell lymphoma: the role of promoter methylation in SOX11 expression

被引:0
|
作者
Agata Magdalena Wasik
Martin Lord
Xiao Wang
Fang Zong
Patrik Andersson
Eva Kimby
Birger Christensson
Mohsen Karimi
Birgitta Sander
机构
[1] Karolinska Institutet and Karolinska University Hospital,Department of Laboratory Medicine, Division of Pathology
[2] Stockholm South Hospital,Department of Hematology
[3] Karolinska Institutet,Division of Hematology, Department of Medicine
[4] Karolinska University Hospital,undefined
[5] Center for Primary Health Care Research,undefined
[6] Lund University Hospital,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The related transcription factors SOX11, SOX4 and SOX12 (classified as the SOXC family) compete for the same target genes. SOX11 is expressed in most mantle cell lymphomas (MCL) but a small subset is, like normal lymphocytes, SOX11 negative. Here we report the variable expression of SOX4 and high expression of SOX12 in MCL compared to non-malignant tissue. Our results show that the expression of the SOXC genes is highly correlated in SOX11 positive MCL. SOX11 expression is epigenetically regulated but there are partly conflicting results regarding the underlying mechanisms. Here we report that the SOX11 promoter region is hypomethylated in both MCL and normal B-lymphocytes. Methylation at other sites is important for sustaining high SOX11 in MCL since treatment with 5-azacytidine decreased SOX11 levels in SOX11 positive MCL cell lines: Granta519 and Rec1. Furthermore, 5-azacytidine treatment of the SOX11 negative MCL cell line, JVM2, induced SOX4 but not SOX11.
引用
收藏
相关论文
共 50 条
  • [31] Role of SOX11 and Genetic Events Cooperating with Cyclin D1 in Mantle Cell Lymphoma
    Sílvia Beà
    Virginia Amador
    Current Oncology Reports, 2017, 19
  • [32] SOX11 expression correlates to promoter methylation and regulates tumor growth in hematopoietic malignancies
    Gustavsson, Elin
    Sernbo, Sandra
    Andersson, Elin
    Brennan, Donal J.
    Dictor, Michael
    Jerkeman, Mats
    Borrebaeck, Carl A. K.
    Ek, Sara
    MOLECULAR CANCER, 2010, 9
  • [33] SOX11 expression correlates to promoter methylation and regulates tumor growth in hematopoietic malignancies
    Elin Gustavsson
    Sandra Sernbo
    Elin Andersson
    Donal J. Brennan
    Michael Dictor
    Mats Jerkeman
    Carl A. K. Borrebaeck
    Sara Ek
    Molecular Cancer, 9
  • [34] Diagnostic accuracy of SOX11 immunohistochemistry in mantle cell lymphoma: A meta-analysis
    Lee, Woojoo
    Shin, Eun
    Kim, Bo-Hyung
    Kim, Hyunchul
    PLOS ONE, 2019, 14 (11):
  • [35] SOX11 is a biomarker for cyclin D1-negative mantle cell lymphoma
    Narurkar R.
    Alkayem M.
    Liu D.
    Biomarker Research, 4 (1)
  • [36] Inconsistency associated with SOX11 immunohistochemistry in mantle cell lymphoma: a meta-analysis
    Lee, Woojoo
    Shin, Eun
    Kim, Bo Hyung
    Kim, Hyunchul
    JOURNAL OF HEMATOPATHOLOGY, 2019, 12 (03) : 109 - 119
  • [37] Inconsistency associated with SOX11 immunohistochemistry in mantle cell lymphoma: a meta-analysis
    Woojoo Lee
    Eun Shin
    Bo Hyung Kim
    Hyunchul Kim
    Journal of Hematopathology, 2019, 12 : 109 - 119
  • [38] Elevated SOX11 mRNA level correlates with favorable prognosis in mantle cell lymphoma
    He, Jianxia
    Xi, Yanfeng
    Gao, Ning
    Xu, Enwei
    Xie, Liwu
    Chang, Jin
    Liu, Jie
    JOURNAL OF BUON, 2019, 24 (04): : 1679 - 1685
  • [39] The utility of mRNA analysis in defining SOX11 expression levels in mantle cell lymphoma and reactive lymph nodes
    Lord, Martin
    Wasik, Agata M.
    Christensson, Birger
    Sander, Birgitta
    HAEMATOLOGICA, 2015, 100 (09) : E369 - E372
  • [40] Regulation of SOX11 expression through CCND1 and STAT3 in mantle cell lymphoma
    Mohanty, Atish
    Sandoval, Natalie
    Phan, An
    Nguyen, Thang V.
    Chen, Robert W.
    Budde, Elizabeth
    Mei, Matthew
    Popplewell, Leslie
    Pham, Lan V.
    Kwak, Larry W.
    Weisenburger, Dennis D.
    Rosen, Steven T.
    Chan, Wing C.
    Muschen, Markus
    Ngo, Vu N.
    BLOOD, 2019, 133 (04) : 306 - 318